Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 52% ± 22% | |
oligodendrocyte | 15 studies | 59% ± 18% | |
glutamatergic neuron | 11 studies | 46% ± 24% | |
oligodendrocyte precursor cell | 11 studies | 41% ± 15% | |
GABAergic neuron | 8 studies | 41% ± 21% | |
endothelial cell | 7 studies | 34% ± 16% | |
epithelial cell | 7 studies | 31% ± 13% | |
fibroblast | 7 studies | 27% ± 12% | |
neuron | 6 studies | 41% ± 21% | |
mesothelial cell | 6 studies | 30% ± 16% | |
interneuron | 6 studies | 45% ± 19% | |
myofibroblast cell | 5 studies | 23% ± 9% | |
adipocyte | 5 studies | 24% ± 8% | |
goblet cell | 5 studies | 28% ± 9% | |
type I pneumocyte | 5 studies | 27% ± 7% | |
granule cell | 4 studies | 48% ± 19% | |
microglial cell | 4 studies | 26% ± 11% | |
retinal pigment epithelial cell | 4 studies | 29% ± 14% | |
retinal cone cell | 4 studies | 25% ± 11% | |
retinal rod cell | 4 studies | 33% ± 9% | |
club cell | 4 studies | 22% ± 7% | |
smooth muscle cell | 4 studies | 25% ± 6% | |
GABAergic interneuron | 3 studies | 31% ± 13% | |
progenitor cell | 3 studies | 38% ± 19% | |
ciliated cell | 3 studies | 21% ± 4% | |
connective tissue cell | 3 studies | 27% ± 4% | |
ependymal cell | 3 studies | 43% ± 20% | |
enteroendocrine cell | 3 studies | 22% ± 6% | |
intestinal crypt stem cell | 3 studies | 21% ± 7% | |
type II pneumocyte | 3 studies | 20% ± 5% | |
basal cell | 3 studies | 29% ± 14% | |
transit amplifying cell | 3 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5057.72 | 245 / 245 | 100% | 73.95 | 502 / 502 |
brain | 100% | 4928.41 | 2641 / 2642 | 100% | 57.19 | 703 / 705 |
ovary | 100% | 5037.62 | 180 / 180 | 99% | 57.39 | 426 / 430 |
kidney | 100% | 3223.00 | 89 / 89 | 97% | 36.87 | 876 / 901 |
intestine | 100% | 7032.86 | 966 / 966 | 97% | 47.51 | 511 / 527 |
thymus | 100% | 3184.63 | 651 / 653 | 97% | 35.17 | 586 / 605 |
stomach | 100% | 3351.71 | 359 / 359 | 95% | 41.49 | 272 / 286 |
pancreas | 97% | 2176.71 | 319 / 328 | 96% | 30.27 | 170 / 178 |
esophagus | 100% | 3686.78 | 1441 / 1445 | 92% | 41.30 | 169 / 183 |
breast | 97% | 2877.89 | 443 / 459 | 94% | 39.35 | 1052 / 1118 |
lung | 99% | 3585.25 | 574 / 578 | 91% | 32.54 | 1053 / 1155 |
uterus | 100% | 4608.64 | 170 / 170 | 88% | 27.51 | 405 / 459 |
skin | 100% | 6892.17 | 1807 / 1809 | 87% | 34.93 | 410 / 472 |
bladder | 100% | 3443.76 | 21 / 21 | 78% | 23.32 | 395 / 504 |
adrenal gland | 92% | 1974.51 | 237 / 258 | 75% | 13.99 | 173 / 230 |
liver | 56% | 663.77 | 127 / 226 | 53% | 12.76 | 214 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 66.38 | 80 / 80 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.56 | 45 / 45 |
blood vessel | 100% | 6135.29 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 3480.45 | 797 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 2580.79 | 1183 / 1204 | 0% | 0 | 0 / 0 |
spleen | 82% | 1124.95 | 197 / 241 | 0% | 0 | 0 / 0 |
heart | 78% | 1335.98 | 668 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.49 | 4 / 29 |
peripheral blood | 2% | 22.58 | 19 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001764 | Biological process | neuron migration |
GO_0060586 | Biological process | multicellular organismal-level iron ion homeostasis |
GO_0007155 | Biological process | cell adhesion |
GO_0050709 | Biological process | negative regulation of protein secretion |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0048681 | Biological process | negative regulation of axon regeneration |
GO_0007520 | Biological process | myoblast fusion |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0007411 | Biological process | axon guidance |
GO_0009306 | Biological process | protein secretion |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0097708 | Cellular component | intracellular vesicle |
GO_0009986 | Cellular component | cell surface |
GO_0098797 | Cellular component | plasma membrane protein complex |
GO_0044295 | Cellular component | axonal growth cone |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0039706 | Molecular function | co-receptor binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0070700 | Molecular function | BMP receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NEO1 |
Protein name | Neogenin (Immunoglobulin superfamily DCC subclass member 2) Neogenin 1 (Neogenin homolog 1 variant) |
Synonyms | IGDCC2 NGN |
Description | FUNCTION: Multi-functional cell surface receptor regulating cell adhesion in many diverse developmental processes, including neural tube and mammary gland formation, myogenesis and angiogenesis. Receptor for members of the BMP, netrin, and repulsive guidance molecule (RGM) families. Netrin-Neogenin interactions result in a chemoattractive axon guidance response and cell-cell adhesion, the interaction between NEO1/Neogenin and RGMa and RGMb induces a chemorepulsive response. . |
Accessions | ENST00000558964.5 [Q92859-4] ENST00000560262.5 [Q92859-3] Q59FP8 ENST00000560328.1 Q92859 ENST00000261908.11 [Q92859-1] ENST00000339362.9 [Q92859-1] |